top
Search terms
Results 1 - 3 of 3 - ordered by :
Epeuropace

HPS VT was considered plausible in patients with (i) impaired left ventricular function associated with dilated cardiomyopathy or valvular heart disease; or (ii) ECG during VT similar to sinus rhythm ...

Europace, ELECTROPHYSIOLOGY, Takao Sakata, Hildegard Tanner, Thomas Stuber, Etienne Delacrétaz

Date : 01/03/2008 Item size : 175124 bytes
Epeuropace

Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy Abstract ...

Europace, Regular Article, T. Pezawas, G. Stix, J. Kastner, M. Wolzt, C. Mayer, D. Moertl, H. Schmidinger

Date : 01/07/2003
Epeuropace

Methods and results We analysed outcomes with respect to death, ICD therapy delivery, and complications for 20 patients with repaired TOF and 39 dilated cardiomyopathy (DCM) patients followed up at a ...

Europace, Implantable cardioverter-defibrillators, Klaus K. Witte, Christopher B. Pepper, J. Campbell Cowan, John D. Thomson, Kate M. English, Michael E. Blackburn

Date : 01/08/2008